PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 19, 2026International Journal of Surgery Case Reports0 citationsOpen Access

Pseudomyogenic hemangioendothelioma of the tibia: a case report

View Full Paper
NTNaoki TakadaNONaoto OebisuHYHana Yao

Key Points

  • This report aims to highlight a rare occurrence of pseudomyogenic hemangioendothelioma in the tibia and the challenges of diagnosis.
  • Case presentation of a 36-year-old man with pain in the lower left leg
  • Diagnostic imaging including X-ray, SPECT/CT, and MRI
  • Curettage procedure performed for biopsy and subsequent consultation
  • FOSB staining used to confirm diagnosis
  • Two discontinuous lytic lesions identified in the cortical bone of the left tibia
  • FOSB staining positive in the nucleus leads to a diagnosis of PMHE
  • No recurrence or metastasis observed at 2-year follow-up

Abstract

Introduction and importance: Pseudomyogenic hemangioendothelioma (PMHE) is a rarely metastasizing intermediate endothelial neoplasm. It typically presents as multiple, discontinuous nodules in the lower extremities of young adult males. Most cases present skin or soft-tissue tumors, but intraosseous lesions without soft-tissue involvement are extremely rare. We report a case of PMHE of the tibia, diagnosed with FOSB staining. Presentation of case: A 36-year-old man presented with pain in the lower left leg after exercise and at night. X-ray, SPECT/CT, and MRI revealed two discontinuous lytic lesions within the cortical bone of the left tibia. A curettage procedure was performed for biopsy, but a diagnosis could not be made for a long time. After further consultation, FOSB staining was positive in the nucleus, leading to a definitive diagnosis of PMHE. No recurrence or metastasis was observed 2 years after surgery. Clinical discussion: PMHE is a rare endothelial tumor, and cases limited to bone without soft tissue involvement are exceptional. Diagnosis is difficult because of overlap with myogenic and epithelioid tumors, but nuclear FOSB staining is a reliable marker. Although local recurrence is frequent, metastasis is rare, underscoring the importance of accurate diagnosis and long-term follow-up. Conclusion: This case highlights the importance of considering PMHE in the differential diagnosis of bone tumors, the utility of FOSB immunostaining in confirming the diagnosis, and the need for long-term follow-up given the high risk of local recurrence.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Takada et al. (2026) studied this question.

synapsesocial.com/papers/6996a7c3ecb39a600b3edc1ehttps://doi.org/10.1097/rc9.0000000000000283
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Soft Tissue Pseudomyogenic Hemangioendothelioma in the Buttock: A Case Report2026
  2. 2Two Cases of Intraosseous Pseudomyogenic (Epithelioid Sarcoma-Like) Hemangioendothelioma With Unusual Features, Expanding the Clinicopathological Spectrum2020 · 4 citations
  3. 3Pseudomyogenic Hemangioendothelioma: A Case of a Solitary Lesion With a Very Indolent Clinical Course2022
  4. 4A Rare Malignant Case of a Primary Pseudomyogenic Haemangioendothelioma of the Bone2025 · 3 citations
  5. 5Primary Pseudomyogenic Hemangioendothelioma of Bone2016 · 75 citations